Okyo Pharma Limited ADR (OKYO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | OKYO | ANTX | AGEN | ||
| Company | Okyo Pharma Limited ADR | An2 Therapeutics Inc | Agenus Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2700 | 1.4600 | 1.6400 | ||
| High | 1.3600 | 1.4900 | 1.6400 | ||
| Low | 1.2700 | 1.4200 | 1.6000 | ||
| Last | 1.3500 | 1.4600 | 1.6100 | ||
| Change | +0.0900 | unch | -0.0600 | ||
| % Change | +7.14% | unch | -3.59% | ||
| Volume | 33,000 | 107,400 | 733,900 | ||
| 20-Day Average Volume | 188,190 | 125,975 | 486,975 | ||
| Previous Close | 1.2600 | 1.4600 | 1.6700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3279 | 1.2897 | 2.2720 | ||
| 20-Day Raw Stochastic | 54.01% | 92.59% | 0.53% | ||
| 20-Day Relative Strength | 55.63% | 67.52% | 27.23% | ||
| Weighted Alpha | +2.38 | -12.75 | -82.56 | ||
| Today's Opinion | 80% Buy | 24% Buy | 100% Sell | ||
| Previous Opinion | 64% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 88% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.52% since 03/14/25 | +4.29% since 03/14/25 | -13.44% since 03/14/25 | ||
| Low | 1.2400 on 03/20/25 | 1.3695 on 03/18/25 | 1.6000 on 03/21/25 | ||
| High | 1.5000 on 03/17/25 | 1.4900 on 03/21/25 | 1.9300 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | +21.08% since 02/21/25 | +29.20% since 02/21/25 | -51.51% since 02/21/25 | ||
| Low | 1.0800 on 02/25/25 | 1.0850 on 02/25/25 | 1.6000 on 03/21/25 | ||
| High | 1.5799 on 03/13/25 | 1.4900 on 03/21/25 | 3.4800 on 02/24/25 | ||
| 3-Month | |||||
| %Chg | +27.36% since 12/20/24 | +15.87% since 12/20/24 | -43.11% since 12/20/24 | ||
| Low | 0.9016 on 01/30/25 | 1.0499 on 02/13/25 | 1.6000 on 03/21/25 | ||
| High | 1.5799 on 03/13/25 | 1.4900 on 03/21/25 | 4.1500 on 01/22/25 | ||
| 6-Month | |||||
| %Chg | +33.66% since 09/20/24 | +39.05% since 09/20/24 | -72.43% since 09/20/24 | ||
| Low | 0.9016 on 01/30/25 | 0.9750 on 11/18/24 | 1.6000 on 03/21/25 | ||
| High | 1.5799 on 03/13/25 | 1.6750 on 11/29/24 | 6.1700 on 09/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,633 | 43,623 | 42,266 | ||
| Shares Outstanding, K | 33,836 | 29,879 | 25,309 | ||
| Annual Sales | 0 | 0 | 103,460,000 | ||
| Annual Net Income | -16,830,000 | -64,730,000 | -232,270,000 | ||
| Last Quarter Sales | N/A | 0 | 26,840,000 | ||
| Last Quarter Net Income | N/A | -12,750,000 | -46,810,000 | ||
| 60-Month Beta | -0.34 | 0.14 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.43 on 11/13/24 | -2.04 on 03/11/25 | ||
| Latest Earnings Date | 08/20/24 | 03/27/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||